The research company Peptonic Medical reports lower revenue in the fourth quarter compared with the same period a year earlier. Operating profit turned positive.Revenue fell 20.5 percent to SEK 3.5 million (4.4).Operating profit was SEK 1 million (-26.7), with an operating margin of 28.6 percent. Profit after tax was SEK -0.2 million (-26.7). Earnings per share amounted to SEK 0.0 (-0.005)."In the coming period, we will intensify our work on geographic expansion. We see clear potential to strengthen our presence in existing markets while gradually establishing ourselves in new ones, both through our own channels and through strategic partnerships. Our ambition is to build a scalable structure that enables international growth while maintaining cost control," says CEO Daniel Rudeklint. Peptonic Medical, SEK millionQ4-2025Q4-2024ChangeNet sales3.54.4-20.5%Operating profit1-26.7Operating margin28.6%Net profit-0.2-26.7Earnings per share, SEK0.0-0.005